For Chewy, however, we are the employer of choice. Our vet recruiting time is 4 months or less against an industry that has taken an average of 12 months to recruit vets. Our vet retention at the ...
Israel is using its wealth—accumulated through technology—to prop up a new vision of territory. But there’s a price to pay. Ultimately, land obsession is harder to remove than politicians expect. It ...
One of the biggest arguments against EVs may soon be squashed should roads in Florida be successful ...
Geleen, May 19th, 2026Matisse Pharmaceuticals B.V., a clinical stage company developing a medicinal product for the treatment of sepsis, today ...
BPF is emerging as a preferred method for security observability over traditional user-space agents. By attaching probes ...
Broad Arrow Auctions, driven by Hagerty (NYSE: HGTY), is celebrating the success of its second annual Concorso d’Eleganza Villa d’Este Auction. As the official auction partner of BMW AG for this ...
The best partnerships in golf rarely feel like transactions. They start with an obvious need, grow through trust and ...
BAKU, Azerbaijan, May 19. The number of grant issuers to those who are biased towards Azerbaijan has dropped, Hikmet Hajiyev, ...
Morning Overview on MSN
Starship V3 will deploy 22 Starlink simulators on Flight 12 — and the last two are designed to photograph the heat shield as it bakes during reentry
SpaceX plans to pack 22 Starlink mass simulators inside the payload bay of its first full-scale Starship V3 vehicle for ...
CMB.TECH ANNOUNCES Q1 2026 RESULTSFIRING ON ALL CYLINDERS ANTWERP, Belgium, 19 May 2026 - CMB.TECH NV ("CMBT", "CMB.TECH" or "the company") (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: ...
Profit for the period of USD 368.8 million in Q1 2026. EBITDA for the same period was USD 558.3 million. CMB.TECH’s contract backlog increased to USD 3.26 billion with the addition of 1 x 5-year ...
New giredestrant data from the lidERA study on its potential as a new standard of care for adjuvant ER-positive breast cancer across all menopausal stages Primary results from the persevERA study on t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results